Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors: An updated analysis Meeting Abstract


Authors: Perreault, S.; Doz, F.; Geoerger, B.; Italiano, A.; Lassen, U.; Nilsson, A.; Nysom, K.; Spano, J. P.; Norenberg, R.; Bernard-Gauthier, V.; de la Cuesta, E.; Drilon, A.; Laetsch, T.; van Tilburg, C.
Abstract Title: Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors: An updated analysis
Meeting Title: 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 25
Issue: Suppl. 5
Meeting Dates: 2023 Nov 15-19
Meeting Location: Vancouver, Canada
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2023-11-01
Start Page: v95
Language: English
ACCESSION: WOS:001115245400358
PROVIDER: wos
DOI: 10.1093/neuonc/noad179.0357
Notes: Meeting Abstract: CTNI-75 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    638 Drilon